May 27 2022




Recommendations

Sulpiride is eliminated through breast milk, although this issue has not been adequately studied.

No signs of influence of the drug have been observed on the infant, but have been detected symptoms attributable to sulpiride in lactating women who were receiving the medicine to increase milk secretion. Such symptoms include fatigue, headaches or swelling of legs.

Available studies on the use of sulpiride to increase milk secretion are inconclusive, so should be avoided its use for this purpose.

This medicine is a psychotropic drug with potential effect on the nervous system and should be considered, like others of the same kind, with unknown effects and possibly with risks for using in lactating women.

Warning of the manufacturer:

If you are breast-feeding a baby, you should not take this medicine due to passing of small amounts into breast milk.

Updated:08.02.08